Replies to post #345291 on Innovation Pharmaceuticals Inc (IPIX)

[thekidzcollegephund]

Not sure I'd get too rattled about this one...

Here is an excerpt...

There are limitations to our study. This is an open-labelled study, which was stopped early due to the impact of the national pandemic control measures and national prioritisation rules for clinical research trials in the UK. Our power calculations were made from the best available predictions in early 2020. Therapeutic randomised clinical trial design and sample size calculations are often dictated by statistical assumptions with treatment effect estimations based on the evidence of best available care. However, in trial design for a new disease, with no known effective treatment, statistical assumptions are thus arbitrary.

For those that want to read the study...

https://www.medrxiv.org/content/10.1101/2021.02.04.21251134v1.full-text

[humpback]

Sorry, but your statement is void of any logic. By your reasoning, you would have us believe, that with a worldwide pandemic, that they would stop at just one therapeutic? Or that after finding one, they wouldn't continue to try and find other more effective therapeutics? Not a big deal for the B market at all. Especially if B ends up as the better choice.

[oddone33320]

Agree, this hurts IPIX but then again will budesonide be effective against mutant variants and other types of Coronavirus, etc?

[CanesNH]

Budesonide like dexamethasone will help you reduce inflammation that causes respiratory distress and that is a big cause of hospitalization but as you know it will not kill the virus so use of one will not preclude using the other. Hopefully they both assist in this pandemic.